Blood cancer is diagnosed at an alarming rate, affecting thousands of families every year. In the UK, more than 40,000 people are diagnosed with blood cancer annually – equivalent to one person receiving the life-changing news approximately every 13 minutes. Globally, the situation is even more stark, with someone being diagnosed with blood cancer every 27 seconds. These figures highlight the urgent need for continued investment in research, clinical trials and specialist research nurses to accelerate the development of new treatments, improve survival rates and, ultimately, find a cure for blood cancer.
James McLaughlin, chief executive of Cure Leukaemia, has spent more than a decade focused on that question. The UK charity is dedicated solely to funding blood cancer research, including clinical trials and the specialist research nurses who deliver them. Rather than providing support services, it funds a network of hospitals that give patients access to new treatments.